Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas
Demographics (2)
- Age - Subject age when sample collected (phv00201613.v1.p1)
- Gender - Sex of subject (phv00201612.v1.p1)
Disease Events (3)
- AFFECTION_STATUS - Case control status of the subject (phv00201605.v1.p1)
- IS_TUMOR - Tumor status (phv00201618.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00201621.v1.p1)
Race and Ethnicity (1)
- Race - Race of participant (phv00201614.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte type (phv00201617.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00201616.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00201604.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00201619.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00201620.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00201615.v1.p1)
- SAMPLE_ID - Sample ID (phv00201607.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00201608.v1.p1)
- SAMPLE_USE - Sample use. CTS_SRA: Custom targeted sequences; SNP_Sequence: SNP genotypes derived from sequence data; WTS_SRA: Whole transcriptome sequencing (phv00201610.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00201622.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00201609.v1.p1)
- SUBJECT_ID - Subject ID (phv00201606.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00201611.v1.p1)
- SUBJECT_ID - Subject ID (phv00201603.v1.p1)